Catherine Ramsey Schulte
Stock Analyst at Robert W. Baird
(4.77)
# 620
Out of 5,126 analysts
586
Total ratings
52.9%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Catherine Ramsey Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Reiterated: Hold | $1,194 → $1,815 | $1,749.01 | +3.77% | 29 | Nov 9, 2026 | |
| NTRA Natera | Reiterated: Buy | $348 → $403 | $319.82 | +26.01% | 43 | Nov 9, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $36 → $39 | $33.99 | +14.74% | 48 | Nov 6, 2026 | |
| GH Guardant Health | Reiterated: Buy | $129 → $196 | $154.78 | +26.63% | 3 | Nov 6, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $22 → $33 | $24.49 | +34.75% | 4 | Nov 5, 2026 | |
| ILMN Illumina | Reiterated: Hold | $137 → $236 | $212.93 | +10.83% | 55 | Nov 5, 2026 | |
| RVTY Revvity | Reiterated: Buy | $117 → $190 | $158.25 | +20.06% | 44 | Nov 4, 2026 | |
| WAT Waters | Reiterated: Buy | $387 → $504 | $470.90 | +7.03% | 45 | Nov 4, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $59 → $92 | $79.43 | +15.83% | 5 | Nov 3, 2026 | |
| DHR Danaher | Reiterated: Buy | $245 → $254 | $235.31 | +7.94% | 31 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $52 | $50.30 | +3.38% | 15 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $639 → $756 | $717.71 | +5.34% | 57 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $115 | $122.59 | -6.19% | 47 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49 → $73 | $72.80 | +0.27% | 43 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 → $156 | $176.95 | -11.84% | 44 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $70 | $125.64 | -44.29% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3 | $7.70 | -61.04% | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $11 | $15.73 | -30.07% | 28 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 8 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 | $89.52 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $2.12 | n/a | 11 | Nov 2, 2018 |
Mettler-Toledo International
Nov 9, 2026
Reiterated: Hold
Price Target: $1,194 → $1,815
Current: $1,749.01
Upside: +3.77%
Natera
Nov 9, 2026
Reiterated: Buy
Price Target: $348 → $403
Current: $319.82
Upside: +26.01%
Castle Biosciences
Nov 6, 2026
Reiterated: Buy
Price Target: $36 → $39
Current: $33.99
Upside: +14.74%
Guardant Health
Nov 6, 2026
Reiterated: Buy
Price Target: $129 → $196
Current: $154.78
Upside: +26.63%
Caris Life Sciences
Nov 5, 2026
Reiterated: Buy
Price Target: $22 → $33
Current: $24.49
Upside: +34.75%
Illumina
Nov 5, 2026
Reiterated: Hold
Price Target: $137 → $236
Current: $212.93
Upside: +10.83%
Revvity
Nov 4, 2026
Reiterated: Buy
Price Target: $117 → $190
Current: $158.25
Upside: +20.06%
Waters
Nov 4, 2026
Reiterated: Buy
Price Target: $387 → $504
Current: $470.90
Upside: +7.03%
Tempus AI
Nov 3, 2026
Reiterated: Buy
Price Target: $59 → $92
Current: $79.43
Upside: +15.83%
Danaher
Oct 22, 2026
Reiterated: Buy
Price Target: $245 → $254
Current: $235.31
Upside: +7.94%
Oct 22, 2026
Reiterated: Buy
Price Target: $43 → $52
Current: $50.30
Upside: +3.38%
Oct 22, 2026
Reiterated: Buy
Price Target: $639 → $756
Current: $717.71
Upside: +5.34%
Aug 4, 2026
Reiterated: Buy
Price Target: $65 → $115
Current: $122.59
Upside: -6.19%
Jun 26, 2026
Reiterated: Hold
Price Target: $49 → $73
Current: $72.80
Upside: +0.27%
May 26, 2026
Reiterated: Buy
Price Target: $155 → $156
Current: $176.95
Upside: -11.84%
May 6, 2026
Reiterated: Buy
Price Target: $82 → $70
Current: $125.64
Upside: -44.29%
Feb 26, 2026
Reiterated: Hold
Price Target: $2 → $3
Current: $7.70
Upside: -61.04%
Feb 12, 2026
Reiterated: Buy
Price Target: $17 → $11
Current: $15.73
Upside: -30.07%
Apr 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 4, 2019
Reiterated: Buy
Price Target: $102
Current: $89.52
Upside: n/a
Nov 2, 2018
Reiterated: Buy
Price Target: $9 → $8
Current: $2.12
Upside: n/a